↓ Skip to main content

Dove Medical Press

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#49 of 179)
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
21 Mendeley
Title
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
Published in
Clinical Pharmacology : Advances and Applications, June 2021
DOI 10.2147/cpaa.s305308
Pubmed ID
Authors

David Gordon, Edward T Hellriegel, Heidi Rath Hope, David Burt, Joseph B Monahan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 14%
Student > Master 3 14%
Student > Postgraduate 3 14%
Researcher 3 14%
Student > Ph. D. Student 2 10%
Other 0 0%
Unknown 7 33%
Readers by discipline Count As %
Medicine and Dentistry 4 19%
Pharmacology, Toxicology and Pharmaceutical Science 3 14%
Unspecified 2 10%
Agricultural and Biological Sciences 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 2 10%
Unknown 7 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#4,839,541
of 25,392,582 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#49
of 179 outputs
Outputs of similar age
#111,775
of 459,810 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#2
of 5 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 179 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.